HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene.

Abstract
Minor histocompatibility antigens (mHags) play an important role in both graft-versus-tumor effects and graft-versus-host disease (GVHD) after allogeneic stem cell transplantation. We applied biochemical techniques and mass spectrometry to identify the peptide recognized by a dominant tumor-reactive donor T-cell reactivity isolated from a patient with relapsed multiple myeloma who underwent transplantation and entered complete remission after donor lymphocyte infusion. A frequently occurring single nucleotide polymorphism in the human ATP-dependent interferon-responsive (ADIR) gene was found to encode the epitope we designated LB-ADIR-1F. Although gene expression could be found in cells from hematopoietic as well as nonhematopoietic tissues, the patient suffered from only mild acute GVHD despite high percentages of circulating LB-ADIR-1F-specific T cells. Differential recognition of nonhematopoietic cell types and resting hematopoietic cells as compared with activated B cells, T cells, and tumor cells was demonstrated, illustrating variable LB-ADIR-1F expression depending on the cellular activation state. In conclusion, the novel mHag LB-ADIR-1F may be a suitable target for cellular immunotherapy when applied under controlled circumstances.
AuthorsCornelis A M van Bergen, Michel G D Kester, Inge Jedema, Mirjam H M Heemskerk, Simone A P van Luxemburg-Heijs, Freke M Kloosterboer, W A Erik Marijt, Arnoud H de Ru, M Ron Schaafsma, Roel Willemze, Peter A van Veelen, J H Frederik Falkenburg
JournalBlood (Blood) Vol. 109 Issue 9 Pg. 4089-96 (May 01 2007) ISSN: 0006-4971 [Print] United States
PMID17234742 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • Epitopes, T-Lymphocyte
  • Minor Histocompatibility Antigens
  • Molecular Chaperones
  • Peptides
  • Adenosine Triphosphatases
  • TOR3A protein, human
Topics
  • Adenosine Triphosphatases (immunology)
  • Antigens, Neoplasm (immunology)
  • Epitope Mapping
  • Epitopes, T-Lymphocyte (immunology)
  • Female
  • Gene Expression Regulation
  • Graft vs Host Disease (immunology)
  • Graft vs Tumor Effect (immunology)
  • Hematopoietic Stem Cells (immunology)
  • Humans
  • Immunotherapy
  • Lymphocyte Activation (immunology)
  • Lymphocyte Transfusion
  • Male
  • Minor Histocompatibility Antigens (immunology)
  • Molecular Chaperones (immunology)
  • Multiple Myeloma (immunology, therapy)
  • Organ Specificity (immunology)
  • Peptides (immunology)
  • Remission Induction
  • Stem Cell Transplantation
  • T-Lymphocytes (immunology)
  • Transplantation Chimera (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: